Time, a Phase 2B/3 Study Evaluating Tg4010 in Combination with First Line Therapy in Advanced Non Small Cell Lung Cancer (Nsclc). Phase 2B Results

Élisabeth Quoix, György Losonczy, Frédéric Forget et al. · Annals of Oncology · 2014

Cited by 4 works. doi:10.1093/annonc/mdu342.8

Authors